In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Aborted sudden cardiac death in an adult with ALCAPA: late was not too late

Session Arrhythmias - Call the electrician!

Speaker Marisa Silva

Congress : ESC Congress 2016

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Acute Cardiac Care - Cardiac Arrest
  • Session type : Clinical Cases
  • FP Number : 4189

M.E. Passos Da Silva1 , T. Dias1 , R. Ladeiras-Lopes1 , A.R. Barbosa1 , J. Neiva2 , J. Almeida1 , P. Neves3 , R. Fontes-Carvalho1 , N. Dias Ferreira1 , V. Gama1 , 1Hospital Center of Vila Nova de Gaia/Espinho, Cardiology - Vila Nova de Gaia - Portugal , 2Hospital de Vila Franca de Xira, Cardiology - Vila Franca de Xira - Portugal , 3Hospital Center of Vila Nova de Gaia/Espinho - Vila Nova de Gaia - Portugal ,

European Heart Journal ( 2016 ) 37 ( Abstract Supplement ), 1418

We report the clinical case of a previous healthy and sporty young woman admitted to the Cardiac Intensive Care Unit for aborted sudden cardiac death.

A 28-year-old sporty woman without relevant medical history had a pre-syncope at home and activated the national emergency system. Upon arrival of the medical team she was still conscious referring vague complaints. She fainted and the EKG showed ventricular fibrillation (VF) that was promptly defibrillated with a 200J shock. Upon return of spontaneous circulation, she had 15 in Glasgow Coma Scale and denied any cardiovascular symptom. The EKG after defibrillation showed sinus tachycardia with voltage criteria for left ventricular (LV) hypertrophy and poor R wave progression in the precordial leads. She remained asymptomatic and hemodynamically stable. Point-of-care transthoracic echocardiography showed moderate LV concentric hypertrophy, global hypokinesia, moderately depressed LV function and no pericardial effusion. High-sensitivity cardiac troponin was slightly elevated (0.045 ng/mL). She was admitted in the Cardiac Intensive Care Unit with the leading diagnosis of myocarditis or hypertrophic cardiomyopathy.

Serial cardiac enzymes were negative. Detailed echocardiographic evaluation revealed moderate LV enlargement, hypokinesia of the basal and mid segments of the anterior and anteroseptal walls and all distal segments, and moderately depressed LV function. Interestingly, there was evidence of possible right coronary artery dilatation or aneurysm and fistulous tracts along the interventricular septum.

Coronary CT angiography showed an anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) and a dilated right coronary artery with extensive collateral network (Fig. 1). To better understand the functional significance of this anomaly and evaluate for myocardial fibrosis, cardiac magnetic resonance (CMR) imaging was performed. There was evidence of subendocardial late gadolinium enhancement in the anterior wall and mid-distal anteroseptum, with transmural extent only in the medium segment of anterior wall. Furthermore, CMR showed extensive peri-infarct ischemia. An invasive coronary angiography confirmed ALCAPA with retrograde filling of the left coronary artery territory through collaterals arising from an enlarged right coronary artery.

This patient was referred for cardiac surgery and will do a coronary button transfer. An ICD will be implanted at discharge.

This clinical case highlights the importance of considering the rare causes of sudden cardiac death, especially in young patients with otherwise unremarkable medical history. Furthermore, it stresses the integrative multimodality imaging approach to thoroughly characterize coronary artery anomalies and plan the management of those patients.

Fig.1 Anomalous origin of the LCA

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are